Abstract.
The chemotherapy of schistosomiasis has improved greatly in the last few decades. There are three drugs available: metrifonate (active against Schistosoma haematobium), oxamniquine (active against Schistosoma mansoni) as narrow spectrum drugs and praziquantel, which is effective against all important adult schistosome species and their immature stages, as the drug of choice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Harder, .A. Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res 88, 395–397 (2002). https://doi.org/10.1007/s00436-001-0588-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00436-001-0588-x